Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:VNDA
일자시간출처헤드라인심볼기업
2017/11/0806:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/11/0806:01PR Newswire (US)Vanda Pharmaceuticals Reports Third Quarter 2017 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/10/2506:00PR Newswire (US)Vanda Pharmaceuticals to Announce Third Quarter 2017 Financial Results on November 7, 2017NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/10/1820:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/10/1107:15PR Newswire (US)Vanda Pharmaceuticals Announces Participation at the Oppenheimer Specialty Pharma Summit ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/10/0222:15PR Newswire (US)Vanda to Present Tradipitant Phase II Atopic Dermatitis Data at World Congress of ItchNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/09/3002:00PR Newswire (US)Vanda to Present Scientific Posters at World Sleep 2017NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/09/1406:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/09/1405:04PR Newswire (US)Vanda's Tradipitant Improves Itch and Disease Severity in Patients with Atopic DermatitisNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/09/1206:00PR Newswire (US)Vanda Pharmaceuticals Announces Participation at September 2017 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/09/0706:00PR Newswire (US)Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech ConferenceNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/08/0320:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/08/0305:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/08/0305:01PR Newswire (US)Vanda Pharmaceuticals Reports Second Quarter 2017 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/07/2120:00PR Newswire (US)Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatme...NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/07/1722:00PR Newswire (US)Vanda Pharmaceuticals to Announce Second Quarter 2017 Financial Results on August 2, 2017NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/07/1103:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/2622:06Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/2006:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/2006:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/2006:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/2006:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/2005:24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/1605:49Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/1605:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/06/0606:00PR Newswire (US)Vanda Pharmaceuticals Announces Participation at June 2017 Investor ConferencesNASDAQ:VNDAVanda Pharmaceuticals Inc
2017/05/0503:10Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/05/0320:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/05/0305:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2017/05/0305:01PR Newswire (US)Vanda Pharmaceuticals Reports First Quarter 2017 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:VNDA